Chemicals Subsector - SEC Form 4 Insider Trading Screener

All Sectors (except Funds) - Chemicals -
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
100 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company Name

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-03-14
SPRBSpruce Biosciences, Inc.Novo Holdings A/s10%S - Sale$0.89-1,912,3164,810,020-28%-$1,698,902
2024-03-18
ACLXArcellx, Inc.Gilson MichelleCFOS - Sale$69.34-6,8259,485-42%-$473,255
D
2024-03-15
HRMYHarmony Biosciences Holdings, Inc.Dierks JeffreyCHIEF COMMERCIAL OFFICERS - Sale+OE$32.00-11,9790-100%-$383,328
2024-03-15
LFVNLifevantage CorpLewis DarwinDirP - Purchase$7.00+449107,5020%+$3,142
D
2024-03-15
ACLXArcellx, Inc.Ware Olivia CDirS - Sale+OE$70.40-9,0000-100%-$633,582
2024-03-14
APLTApplied Therapeutics, Inc.Shendelman ShoshanaPres, CEO, 10%S - Sale$5.39-318,5738,148,305-4%-$1,717,108
2024-03-14
APLTApplied Therapeutics, Inc.Perfetti RiccardoChief Medical OfficerS - Sale$5.39-110,8041,031,537-10%-$597,234
2024-03-14
APLTApplied Therapeutics, Inc.Hansard AdamChief Commercial OfficerS - Sale$5.39-48,871732,919-6%-$263,415
M
2024-03-14
IMRXImmuneering CorpCormorant Asset Management, LP10%S - Sale$3.02-909,0913,295,273-22%-$2,749,003
2024-03-14
APLTApplied Therapeutics, Inc.Funtleyder Leslie D.CFOS - Sale$5.39-28,727308,421-9%-$154,839
2023-01-09
MIRMMirum Pharmaceuticals, Inc.Radovich PeterPres, COOS - Sale$20.62-1,37933,316-4%-$28,438
D
2024-03-15
CRSPCrispr Therapeutics AGPrasad RajuCFOS - Sale+OE$72.69-3,5246,476-35%-$256,160
D
2024-03-15
CRSPCrispr Therapeutics AGKulkarni SamarthCEOS - Sale+OE$72.48-20,000408,122-5%-$1,449,628
2023-01-09
MIRMMirum Pharmaceuticals, Inc.Vig PamelaChief Scientific OfficerS - Sale$20.62-1,379102,312-1%-$28,438
2019-09-10
MIRMMirum Pharmaceuticals, Inc.Longpre LaraChief Development OfficerP - Purchase$10.64+965104,369+1%+$10,268
2023-01-09
MIRMMirum Pharmaceuticals, Inc.Longpre LaraChief Development OfficerS - Sale$20.62-1,003104,369-1%-$20,684
2023-01-09
MIRMMirum Pharmaceuticals, Inc.Peetz ChristopherCEOS - Sale$20.62-5,159300,523-2%-$106,390
2024-03-18
MIRMMirum Pharmaceuticals, Inc.Bjerkholt EricCFOP - Purchase$25.80+2,00012,000+20%+$51,600
D
2024-03-14
MAIAMaia Biotechnology, Inc.Chaouki Steven MDirP - Purchase$1.17+34,64188,891+64%+$40,530
M
2024-03-14
RNACCartesian Therapeutics, Inc.Springer Timothy ADir, 10%P - Purchase$0.56+1,185,87238,612,405+3%+$666,222
D
2024-03-15
CSWICsw Industrials, Inc.Armes Joseph BCOB, Pres, CEOS - Sale+OE$230.06-1,00051,497-2%-$230,057
D
2024-03-14
RGNXRegenxbio Inc.Mills Kenneth T.Pres, CEOS - Sale+OE$21.86-15,000408,035-4%-$327,942
M
2024-03-11
UPXIUpexi, Inc.Marshall AllanCEO, 10%P - Purchase$0.58+77,7732,939,654+3%+$44,739
2024-03-18
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$0.87+500,000244,164,3530%+$437,100
2024-03-18
ZTSZoetis Inc.Lagano RoxanneEVPS - Sale$173.33-92316,517-5%-$159,984
2024-03-15
APLSApellis Pharmaceuticals, Inc.Chopas James GeorgeVP, Chief Accounting OfficerS - Sale$56.46-18438,8830%-$10,389
2024-03-14
ALXOAlx Oncology Holdings IncLettmann JasonCEOP - Purchase$11.31+4,400171,620+3%+$49,771
2024-03-14
TWSTTwist Bioscience CorpCho DennisSee RemarksS - Sale$34.60-9381,3630%-$3,218
2024-03-18
ALKSAlkermes Plc.Nichols Christian ToddSVP, Chief Commercial OfficerS - Sale$28.10-10,41765,911-14%-$292,740
2024-03-15
AIMAim Immunotech Inc.Appelrouth StewartDirP - Purchase$0.33+90,910239,765+61%+$30,000
2024-03-15
AIMAim Immunotech Inc.Equels Thomas KCEO, PresP - Purchase$0.33+75,758716,455+12%+$25,000
2024-03-15
AIMAim Immunotech Inc.Rodino Peter W IIICOO, Secretary, Gen. CounselP - Purchase$0.33+37,879181,718+26%+$12,500
2024-03-14
RZLTRezolute, Inc.Roberts Brian KennethChief Medical OfficerP - Purchase$1.88+10,00053,128+23%+$18,800
A
2024-03-07
RZLTRezolute, Inc.Roberts Brian KennethChief Medical OfficerP - Purchase$1.85+50043,128+1%+$925
2024-03-15
WLKWestlake CorpBuesinger Robert F.EVP, HIP, IT, DigitalS - Sale$144.50-3,87821,144-15%-$560,371
M
2024-03-13
ADMAAdma Biologics, Inc.Elms SteveDirS - Sale$6.11-1,038,2842,653,828-28%-$6,339,418
DM
2024-03-14
AXSMAxsome Therapeutics, Inc.Jeffs RogerDirS - Sale+OE$69.84-32,323167,668-16%-$2,257,449
2024-03-14
ASRTAssertio Holdings, Inc.Tyree James LDirS - Sale$1.12-10,251188,251-5%-$11,463
M
2024-03-13
IGMSIgm Biosciences, Inc.Weber StevenPrincipal Accounting OfficerS - Sale$10.01-99326,507-4%-$9,943
M
2024-03-13
SPRYArs Pharmaceuticals, Inc.Lowenthal Richard EPres, CEO, 10%S - Sale$9.14-100,00012,846,116-1%-$913,681
M
2024-03-13
IGMSIgm Biosciences, Inc.Takimoto Chris HChief Medical OfficerS - Sale$10.01-5,42494,388-5%-$54,312
M
2024-03-13
IGMSIgm Biosciences, Inc.Tahir MisbahCFOS - Sale$10.01-5,44090,418-6%-$54,472
M
2024-03-13
SPRYArs Pharmaceuticals, Inc.Tanimoto SarinaChief Medical Officer, 10%S - Sale$9.14-100,00012,846,116-1%-$913,681
M
2024-03-13
IGMSIgm Biosciences, Inc.Schwarzer FredCEO, PresS - Sale$10.01-8,947413,369-2%-$89,588
M
2024-03-13
IGMSIgm Biosciences, Inc.Keyt BruceChief Scientific OfficerS - Sale$10.01-3,945175,895-2%-$39,502
M
2024-03-13
IGMSIgm Biosciences, Inc.Decker Lisa LynnChief Business OfficerS - Sale$10.01-3,37661,006-5%-$33,805
M
2024-03-14
KYMRKymera Therapeutics, Inc.Booth BruceDirS - Sale$40.25-127,543806,697-14%-$5,133,263
A
2024-01-10
FOLDAmicus Therapeutics, Inc.Crowley John FExec COBS - Sale$13.65-31,614927,013-3%-$431,452
D
2024-03-14
MAIAMaia Biotechnology, Inc.Smith StanDirP - Purchase$1.17+170,940857,568+25%+$200,000
D
2024-03-14
MAIAMaia Biotechnology, Inc.Louie Ngar YeeDirP - Purchase$1.17+170,9401,147,524+18%+$200,000
D
2024-03-14
MAIAMaia Biotechnology, Inc.Luput CristianDirP - Purchase$1.17+69,282367,350+23%+$81,060
D
2024-03-14
MAIAMaia Biotechnology, Inc.Guerrero RamiroDirP - Purchase$1.17+6,928319,600+2%+$8,106
2024-03-13
MRNAModerna, Inc.Afeyan NoubarDirS - Sale$108.54-15,00011,797,9690%-$1,628,031
D
2024-03-13
SUPNSupernus Pharmaceuticals, Inc.Bhatt Padmanabh P.SVP of IP, CSOS - Sale+OE$33.74-62,3668,570-88%-$2,104,289
2024-03-13
CSWICsw Industrials, Inc.Sullivan DonEVP, GM Contractor SolutionsS - Sale$230.90-7,82628,956-21%-$1,807,032
2024-03-13
VTRSViatris IncMauro AnthonySee RemarksS - Sale$12.09-250,000248,618-50%-$3,023,700
D
2024-03-14
NBIXNeurocrine Biosciences IncBenevich EricChief Commercial OfficerS - Sale+OE$139.38-75,00040,778-65%-$10,453,418
D
2024-03-13
NBIXNeurocrine Biosciences IncPops Richard FDirS - Sale+OE$140.33-23,20029,512-44%-$3,255,621
D
2024-03-13
NBIXNeurocrine Biosciences IncDelaet IngridChief Regulatory OfficerS - Sale+OE$140.14-3,0007,507-29%-$420,419
2024-03-13
BPMCBlueprint Medicines CorpLee PhilinaCHIEF COMMERCIAL OFFICERS - Sale$90.40-8,02334,729-19%-$725,277
2024-03-13
AKROAkero Therapeutics, Inc.Yale CatrionaChief Development OfficerS - Sale$28.33-72377,692-1%-$20,483
2024-03-13
AKROAkero Therapeutics, Inc.White William RichardCFOS - Sale$28.33-72449,630-1%-$20,511
2024-03-13
AKROAkero Therapeutics, Inc.Cheng AndrewPres, CEOS - Sale$28.33-1,969589,4470%-$55,782
2024-03-13
AKROAkero Therapeutics, Inc.Young JonathanCOOS - Sale$28.33-651328,3060%-$18,443
2024-03-13
AKROAkero Therapeutics, Inc.Rolph TimothyChief Scientific OfficerS - Sale$28.33-619182,5580%-$17,536
2024-03-13
TGTXTg Therapeutics, Inc.Lonial SagarDirS - Sale$15.94-5,000108,878-4%-$79,675
DM
2024-03-13
UTHRUnited Therapeutics CorpRothblatt Martine ACHAIRPERSON, CEOS - Sale+OE$240.31-30,000130-100%-$7,209,192
2024-03-13
LNTHLantheus Holdings, Inc.Sabens AndreaChief Accounting OfficerS - Sale$60.48-34163,204-1%-$20,624
2024-03-14
CFCf Industries Holdings, Inc.Hoker Richard AVP, Corporate ControllerS - Sale$84.11-11,02954,416-17%-$927,612
M
2024-03-14
CECelanese CorpRichardson Scott AEVP, COOS - Sale$156.67-4,00075,012-5%-$626,680
2024-03-14
CECelanese CorpKelly Thomas FrancisSVP, EMP - Purchase$156.70+1,40057,023+3%+$219,373
2024-03-13
SKYESkye Bioscience, Inc.5Am Partners Vii, LLC10%P - Purchase$10.00+450,00010,179,505+5%+$4,500,000
D
2024-03-13
RNAAvidity Biosciences, Inc.Maclean Michael FCFOS - Sale+OE$24.52-40,00044,093-48%-$980,760
DM
2024-03-13
VCELVericel CorpColangelo DominickPres, CEOS - Sale+OE$44.35-35,000194,870-15%-$1,552,075
A
2024-03-08
VCELVericel CorpFlynn Sean C.SVP, GCS - Sale$45.33-8,115167-98%-$367,853
D
2024-03-14
REGNRegeneron Pharmaceuticals, Inc.Murphy Andrew JEVP ResearchS - Sale+OE$956.47-5,78352,616-10%-$5,531,290
2024-03-15
ANIXAnixa Biosciences IncBaskies Arnold MDirP - Purchase$3.63+10,000110,000+10%+$36,300
2024-03-15
ANIXAnixa Biosciences IncKumar AmitCEOP - Purchase$3.22+30,000491,925+6%+$96,600
M
2024-03-12
CMPSCompass Pathways PlcGoldsmith George JayDir, 10%S - Sale$10.70-65,8868,121,534-1%-$704,821
M
2024-03-12
CMPSCompass Pathways PlcMalievskaia EkaterinaDir, 10%S - Sale$10.70-65,8868,121,534-1%-$704,821
2024-03-14
XERSXeris Biopharma Holdings, Inc.Schmid John P.DirP - Purchase$2.16+4,50074,159+6%+$9,720
D
2024-03-13
APREAprea Therapeutics, Inc.Hamill John P.SrVP, CFO, Prin Fin, Acct OfcrP - Purchase$7.29+1,01015,503+7%+$7,363
D
2024-03-13
APREAprea Therapeutics, Inc.Seizinger Bernd R.DirP - Purchase$7.29+6,86033,685+26%+$50,009
D
2024-03-13
APREAprea Therapeutics, Inc.Henneman John B IIIDirP - Purchase$7.29+6,8608,139+536%+$50,009
D
2024-03-13
APREAprea Therapeutics, Inc.Gilad OrenPres, CEOP - Purchase$7.29+2,000324,770+1%+$14,580
DM
2024-03-12
RXRXRecursion Pharmaceuticals, Inc.Secora MichaelCFOS - Sale+OE$10.74-50,0001,204,179-4%-$537,190
DM
2024-03-12
AVTEAerovate Therapeutics, Inc.Eldridge George ASEE REMARKSS - Sale+OE$25.03-4,0671,960-67%-$101,815
M
2024-03-12
BGNEBeigene, Ltd.Oyler JohnCEOS - Sale$167.36-50,00048,162,3170%-$8,368,017
2022-12-29
SHPHShuttle Pharmaceuticals Holdings, Inc.Senanayake ChrisDirS - Sale$1.61-1,6262,791-37%-$2,610
2024-03-14
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$0.89+500,000243,664,3530%+$444,300
D
2024-03-12
SUPNSupernus Pharmaceuticals, Inc.Bhatt Padmanabh P.SVP of IP, CSOS - Sale+OE$32.99-3,8848,570-31%-$128,133
2024-03-14
CGTXCognition Therapeutics IncRicciardi LisaCEO, PresP - Purchase$1.75+5,700291,345+2%+$9,975
2024-03-13
APLSApellis Pharmaceuticals, Inc.Nicholson NurChief Technical OfficerS - Sale$57.56-11,22056,287-17%-$645,838
D
2024-03-12
LYBLyondellbasell Industries N.V.McMurray Michael C.EVP, CFOS - Sale+OE$100.84-16,94088,858-16%-$1,708,219
2024-03-13
DDDupont De Nemours, Inc.Goss Michael G.ControllerS - Sale$72.80-2,35415,587-13%-$171,371
DM
2024-03-04
LNZALanzatech Global, Inc.Burton FreyaChief Sustainability OfficerS - Sale+OE$3.20-87,49349,846-64%-$280,123
2024-03-13
WLKWestlake CorpBuesinger Robert F.EVP, HIP, IT, DigitalS - Sale$144.50-12225,0220%-$17,629
M
2022-07-22
RZLTRezolute, Inc.Kim Young-JinDirP - Purchase$3.20+115,4506,058,067+2%+$369,858
D
2024-03-13
CHDChurch & Dwight Co Inc /de/Bruno Barry A.EVP, Chf Mktng Offcr Pres CDS - Sale+OE$104.55-9,9267,228-58%-$1,037,805
2024-03-13
CRMDCormedix Inc.Todisco JosephCEOP - Purchase$3.74+13,561352,839+4%+$50,718

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top